Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 155c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($1.68), $1.55 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• JPMorgan Assumes Kanzhun Ltd. (BZ) at Overweight
• Trifecta Gold closes $1.66M private placement for Yukon exploration